Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 1628352, 11 pages
http://dx.doi.org/10.1155/2016/1628352
Research Article

Delta-Like-1 Changes the Immunomodulatory Property of OP9 Cells

1Laboratory of Animal Genetic Breeding and Reproduction, Yanbian University, Yanji, Jilin 133002, China
2Department of Advanced Interdisciplinary Studies, Institute of Basic Medical Sciences, 27 Taiping Road, Haidian District, Beijing 100850, China
3Department of Biology and Chemical Engineering, Tongren University, Tongren, Guizhou 554300, China
4Beijing Aiyuhua Hospital for Children and Women, 2 South Street, Beijing Economic and Technological Development Zone, Beijing 100176, China
5307-Ivy Translational Medicine Center, Laboratory of Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China

Received 29 January 2015; Revised 10 April 2015; Accepted 20 April 2015

Academic Editor: Vladislav Volarevic

Copyright © 2016 Lei Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. G. Osmond, “Production and selection of B lymphocytes in bone marrow: lymphostromal interactions and apoptosis in normal, mutant and transgenic mice,” Advances in Experimental Medicine and Biology, vol. 355, pp. 15–20, 1994. View at Google Scholar · View at Scopus
  2. G. Anderson, N. C. Moore, J. J. T. Owen, and E. J. Jenkinson, “Cellular interactions in thymocyte development,” Annual Review of Immunology, vol. 14, pp. 73–99, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Nakano, “In vitro development of hematopoietic system from mouse embryonic stem cells: a new approach for embryonic hematopoiesis,” International Journal of Hematology, vol. 65, no. 1, pp. 1–8, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Suzuki and T. Nakano, “Development of hematopoietic cells from embryonic stem cells,” International Journal of Hematology, vol. 73, no. 1, pp. 1–5, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Carlyle, A. M. Michie, C. Furlonger et al., “Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes,” The Journal of Experimental Medicine, vol. 186, no. 2, pp. 173–182, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. J. S. Yuan, P. C. Kousis, S. Suliman, I. Visan, and C. J. Guidos, “Functions of notch signaling in the immune system: consensus and controversies,” Annual Review of Immunology, vol. 28, pp. 343–365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Radtke, N. Fasnacht, and H. R. MacDonald, “Notch signaling in the immune system,” Immunity, vol. 32, no. 1, pp. 14–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Tanigaki and T. Honjo, “Regulation of lymphocyte development by Notch signaling,” Nature Immunology, vol. 8, no. 5, pp. 451–456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. T. M. Schmitt and J. C. Zúñiga-Pflücker, “Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro,” Immunity, vol. 17, no. 6, pp. 749–756, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Gao, X.-L. Yan, R. Li et al., “Characterization of OP9 as authentic mesenchymal stem cell line,” Journal of Genetics and Genomics, vol. 37, no. 7, pp. 475–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Ren, L. Zhang, X. Zhao et al., “Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide,” Cell Stem Cell, vol. 2, no. 2, pp. 141–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Xu, L. Zhang, G. Ren et al., “Immunosuppressive properties of cloned bone marrow mesenchymal stem cells,” Cell Research, vol. 17, no. 3, pp. 240–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. E. J. Bassi, D. C. de Almeida, P. M. M. Moraes-Vieira, and N. O. S. Câmara, “Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells,” Stem Cell Reviews and Reports, vol. 8, no. 2, pp. 329–342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Kristjánsson and S. Honsawek, “Current perspectives in mesenchymal stem cell therapies for osteoarthritis,” Stem Cells International, vol. 2014, Article ID 194318, 13 pages, 2014. View at Publisher · View at Google Scholar
  15. A. Dorronsoro, I. Ferrin, J. M. Salcedo et al., “Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB,” European Journal of Immunology, vol. 44, no. 2, pp. 480–488, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. Kang, K.-S. Kang, H. C. Koo, J. R. Park, E. W. Choi, and Y. H. Park, “Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells,” Stem Cells and Development, vol. 17, no. 4, pp. 681–693, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Chen, D. Wang, W. T. Du et al., “Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism,” Clinical Immunology, vol. 135, no. 3, pp. 448–458, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. J. Nauta and W. E. Fibbe, “Immunomodulatory properties of mesenchymal stromal cells,” Blood, vol. 110, no. 10, pp. 3499–3506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. X.-X. Jiang, Y. Zhang, B. Liu et al., “Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells,” Blood, vol. 105, no. 10, pp. 4120–4126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. de Smedt, I. Hoebeke, and J. Plum, “Human bone marrow CD34+ progenitor cells mature to T cells on OP9-DL1 stromal cell line without thymus microenvironment,” Blood Cells, Molecules, and Diseases, vol. 33, no. 3, pp. 227–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Palaga, L. Miele, T. E. Golde, and B. A. Osborne, “TCR-mediated Notch signaling regulates proliferation and IFN-γ production in peripheral T cells,” The Journal of Immunology, vol. 171, no. 6, pp. 3019–3024, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M.-L. Nueda, V. Baladrón, B. Sánchez-Solana, M.-Á. Ballesteros, and J. Laborda, “The EGF-like protein dlk1 inhibits notch signaling and potentiates adipogenesis of mesenchymal cells,” Journal of Molecular Biology, vol. 367, no. 5, pp. 1281–1293, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Huang, X. Yang, Y. Wu et al., “γ-secretase inhibitor induces adipogenesis of adipose-derived stem cells by regulation of Notch and PPAR-γ,” Cell Proliferation, vol. 43, no. 2, pp. 147–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Kutleša, J. Zayas, A. Valle, R. B. Levy, and R. Jurecic, “T-cell differentiation of multipotent hematopoietic cell line EML in the OP9-DL1 coculture system,” Experimental Hematology, vol. 37, no. 8, pp. 909.e1–923.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. E. H. Schroeter, J. A. Kisslinger, and R. Kopan, “Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain,” Nature, vol. 393, no. 6683, pp. 382–386, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Struhl and A. Adachi, “Nuclear access and action of Notch in vivo,” Cell, vol. 93, no. 4, pp. 649–660, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Santos, L. M. Sarmento, M. Rebelo et al., “Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 39, pp. 15454–15459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. J. C. Pui, D. Allman, L. Xu et al., “Notch1 expression in early lymphopoiesis influences B versus T lineage determination,” Immunity, vol. 11, no. 3, pp. 299–308, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Taghon, I. D. Van Walle, G. De Smet et al., “Notch signaling is required for proliferation but not for differentiation at a well-defined β-selection checkpoint during human T-cell development,” Blood, vol. 113, no. 14, pp. 3254–3263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J.-A. Kang, W.-S. Kim, and S.-G. Park, “Notch1 is an important mediator for enhancing of B-cell activation and antibody secretion by Notch ligand,” Immunology, vol. 143, no. 4, pp. 550–559, 2014. View at Publisher · View at Google Scholar
  32. C. Chen, K. Akiyama, T. Yamaza et al., “Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression,” EMBO Molecular Medicine, vol. 6, no. 3, pp. 322–334, 2014. View at Publisher · View at Google Scholar
  33. M. M. Duffy, J. Pindjakova, S. A. Hanley et al., “Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor,” European Journal of Immunology, vol. 41, no. 10, pp. 2840–2851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener, and D. Dilloo, “Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation,” Blood, vol. 103, no. 12, pp. 4619–4621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Sato, K. Ozaki, I. Oh et al., “Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells,” Blood, vol. 109, no. 1, pp. 228–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Zhang, R.-J. Dang, H. Li et al., “SOCS1 regulates the immune modulatory properties of mesenchymal stem cells by inhibiting nitric oxide production,” PLoS ONE, vol. 9, no. 5, Article ID e97256, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. D. Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. S.-H. Yang, M.-J. Park, I.-H. Yoon et al., “Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10,” Experimental & Molecular Medicine, vol. 41, no. 5, pp. 315–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. K. N. Sivanathan, S. Gronthos, D. Rojas-Canales, B. Thierry, and P. T. Coates, “Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation,” Stem Cell Reviews and Reports, vol. 10, no. 3, pp. 351–375, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. A. El-Sehemy, A. C. Chang, A. K. Azad et al., “Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells,” Cellular Signalling, vol. 25, no. 12, pp. 2780–2787, 2013. View at Publisher · View at Google Scholar · View at Scopus